Tag: lung cancer research

An Update on the Burn Pits Accountability Act of 2019

an-update-on-the-burn-pits-accountability-act-of-2019

Click here to read our statement in support of the legislation. GO2 Foundation for Lung Cancer is pleased to report the recent advancement of the Burn Pits Accountability Act. We strongly support this legislation as a first step to ensure that all those affected by burn pit toxins are accounted […]

New Treatment Approved for Metastatic Small Cell Lung Cancer

new-treatment-approved-for-metastatic-small-cell-lung-cancer

On June 17, 2019, the U.S. Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA) for patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy. Though pembrolizumab is an established treatment option for […]

Early Screening Equals Early Diagnosis

early-screening-equals-early-diagnosis

GO2 Foundation for Lung Cancer’s recently published scientific paper found that lung cancer screening programs can successfully detect lung cancer early with the majority of lung cancers diagnosed at stage 1 or limited stage. Importantly, outcomes at academic and nonacademic sites were compared and the data confirmed that responsible screening […]

Women’s Health Week: Our Fight Against Lung Cancer

women’s-health-week:-our-fight-against-lung-cancer

Lung cancer in women is a critical women’s health issue in the United States. An average of 181 women die each day of lung cancer—one every 8 minutes. In fact, two-thirds of the never-smoked lung cancer population is female. Why does the number of young women with lung cancer who […]

Join Our $20 Million By 2020 Campaign to Restore Full Funding for Lung Cancer Research!

join-our-$20-million-by-2020-campaign-to-restore-full-funding-for-lung-cancer-research!

Through consistent advocacy efforts, GO2­ Foundation (formerly Lung Cancer Alliance) established the Lung Cancer Research Program (LCRP) within the Congressionally Directed Medical Research Programs, administered by the Department of Defense with federal appropriations of $20 million in Fiscal Year (FY) 2009. LCRP has been underfunded the past 10 years, below […]

Research Wins Big

research-wins-big

The GO2 Foundation for Lung Cancer is honored to announce that on May 2 two of our programs received Your Cancer’s Cancer Community (C2) Awards. These awards celebrate “the unsung heroes of cancer care”—individuals and organizations that advance cancer care and work to improve the lives of those living with […]

Lung Cancer Registry Allows Patients to Help Fight Lung Cancer

lung-cancer-registry-allows-patients-to-help-fight-lung-cancer

Each year, more than 1.8 million people receive a lung cancer diagnosis. Though research and treatment options have come a long way, there is still far more work to be done to stop the number one cancer killer. The Lung Cancer Registry was created for anyone who has been diagnosed […]

FDA Approves First-Line Treatment for NSCLC with PD-L1 Biomarker

fda-approves-first-line-treatment-for-nsclc-with-pd-l1-biomarker

On April 11, the U.S. Food and Drug Administration approved pembrolizumab (KEYTRUDA) as a first-line treatment for patients with advanced NSCLC who have a score of 1% or higher on the PD-L1 biomarker test. The approval was based on KEYNOTE-042 trial which demonstrated statistically significant OS improvements for those randomized […]